Candel Therapeutics, Inc. short interest in 2024
In 2024, Candel Therapeutics, Inc.'s disclosed short interest ran from 0.55% of shares outstanding on 28 Mar 2024 to 9.42% on 31 Dec 2024, a change of +8.87 percentage points. The year's high was 14.07% on 13 Dec 2024 and its low 0.55% on 28 Mar 2024, averaging 6.22% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.09 days on 30 Aug 2024. Full history: Candel Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.55% (28 Mar 2024)
- End of year
- 9.42% (31 Dec 2024)
- Change
- +8.87 pp
- High
- 14.07% (13 Dec 2024)
- Low
- 0.55% (28 Mar 2024)
- Average
- 6.22%
- Highest days to cover
- 8.09 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 28 Mar 2024 | 0.55% | 4.49 | 10-K filed, results (8-K) |
| 15 Aug 2024 | 5.08% | 7.01 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 30 Aug 2024 | 5.26% | 8.09 | |
| 13 Sep 2024 | 5.26% | 6.26 | |
| 30 Sep 2024 | 4.95% | 4.76 | |
| 15 Oct 2024 | 5.11% | 8.05 | |
| 31 Oct 2024 | 5.55% | 7.20 | |
| 15 Nov 2024 | 6.46% | 6.03 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 6.71% | 3.10 | |
| 13 Dec 2024 | 14.07% | 1.00 | |
| 31 Dec 2024 | 9.42% | 1.00 |
See also: Candel Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.